Ron Wyden sold Pfizer Inc (NYSE: PFE)
Ron Wyden sold PFE · disclosed July 2, 2025
Ron Wyden, a OR Senate member representing District N/A, sold $1,001 - $15,000 of Pfizer Inc (PFE) on June 3, 2025. Filings associated with Ron Wyden disclosed 0 other PFE transactions in the 12 months before this trade. Shares of PFE have risen 30.4% since the first observed purchase on June 3, 2025. The filing was publicly disclosed on July 2, 2025; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Ron Wyden's complete filing history, visit Ron Wyden's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- Analyst ratings on PFE break down as 0 strong buy, 5 buy, 8 hold, 1 sell, 0 strong sell.
- PFE carries a Risk Score of 100 as of September 4, 2026. On this scale, a higher score means a lower risk surface.
- Ron Wyden sold PFE in the amount range of $1,001 - $15,000 on June 3, 2025, filed under the STOCK Act.
- The filing lists Spouse as the transaction owner and was disclosed 29 days after the trade.
- The asset description in the filing reads 'Pfizer, Inc. Common Stock.'
- Filings associated with Ron Wyden disclosed 0 other PFE transactions in the 12 months before this trade.
- Shares of PFE have risen 30.4% since the first observed purchase on June 3, 2025.
- PFE carried a Q Score of 75.2 in its equity peer group as of September 4, 2026.
- PFE carried a Squeeze Score of 17 as of September 8, 2026.
Did Ron Wyden buy or sell PFE?
The Periodic Transaction Report covers a single sale involving PFE on June 3, 2025. The filed amount range is $1,001 - $15,000. The asset description reads 'Pfizer, Inc. Common Stock', as submitted by the filer. The report was submitted on July 2, 2025. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| Ron Wyden (Senate) | Sell | PFE | $1,001 - $15,000 | June 3, 2025 | July 2, 2025 |
What other PFE trades has Ron Wyden disclosed in the past 12 months?
Filings associated with Ron Wyden disclosed 0 other PFE transactions in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| No other PFE transactions were disclosed in the prior 12 months. | ||||
What does the filing show, and what does it not show?
The filing reports a sale involving PFE by Ron Wyden in the amount range of $1,001 - $15,000, with Spouse listed as the owner. It does not establish Ron Wyden's total holdings in PFE, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Pfizer, Inc. Common Stock', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Ron Wyden's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Ron Wyden disclosed 0 other PFE transactions in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded PFE?
Quantellect's current database lists these recent PFE disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| Rohit Khanna Dependent child | D House | Buy | $1,001 - $15,000 | August 7, 2026Filing unavailable |
| Rohit Khanna Spouse | D House | Sell | $1,001 - $15,000 | July 6, 2026Filing unavailable |
| Tommy Tuberville Joint | R Senate | Sell | $15,001 - $50,000 | July 16, 2026Filing unavailable |
| Rohit Khanna Dependent child | D House | Sell | $15,001 - $50,000 | July 6, 2026Filing unavailable |
| Rohit Khanna Spouse | D House | Buy | $1,001 - $15,000 | June 9, 2026Filing unavailable |
How has Ron Wyden's disclosed trading performed?
A current measured Q Score is not available for this member. Quantellect does not infer performance where the scored-trade projection lacks coverage.
All Ron Wyden PFE trades
Frequently asked questions
Did Ron Wyden buy or sell PFE?
According to the disclosure, Ron Wyden sold PFE on June 3, 2025.
What amount was reported for the PFE transaction?
The disclosure reports $1,001 - $15,000 for the sale. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated June 3, 2025, and it was disclosed on July 2, 2025.
Where can I see Ron Wyden's other congressional trades?
Quantellect lists Ron Wyden's complete disclosed trade history on the member profile. Ron Wyden's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.